Basilea announced this morning the receipt of another milestone from partner Pfizer with respect to Cresemba's sales performance in the...

Basilea has announced that Zevtera (ceftobiprole) is now available in the US through its commercial partner Innoviva Specialty...

Basilea's 2024 financial results reflect another year of strong financial and operational progress. Total revenues of CHF 208.5m...